You Position: Home > Paper

Nationwide multicentre clinical research on flurbiprofen cataplasm for treating patients with osteoarthritis pain

( views:200, downloads:435 )
Author:
No author available
Journal Title:
Chinese Journal of Rheumatology
Issue:
9
DOI:
10.3760/cma.j.issn.1007-7480.2012.09.007
Key Word:
氟比洛芬;骨关节炎,膝;疼痛;Flurbiprofen;Osteoarthritis,knee;Pain

Abstract: Objective To study the effect and safety of flurbiprofen cataplasm on osteoarthritis pain in Chinese patients.Methods One hundred and eighty-three patients were divided into flurbiprofen cataplasm group,indometacin cataplasm group and Qizheng-xiaotong plaster group randomly.The score of pain,stiffness and physical function were analyzed with WOMAC scale and adverse reactions were also assessed.KruskalWallis H test,Nemenyi test and CMH tese were used.Results After treatment,the VAS value of the three groups decreased significantly and the VAS difference value of the flurbiprofen cataplasm group changed the most significantly (the changes of VAS value in flat walking,up and down stairs,nighttime,rest and weightbearing were 31±21,35±20,24±19,20±18 and 37±20 respectively).Meanwhile,the value of stiffness and physical function decreased significantly.In terms of safety,flurbiprofen cataplasm group and the indome-tacin cataplasm group were better than Qizheng-xiaotong plaster group.But in sense of constriction,the flurbiprofen cataplasm group was better than the indometacin eataplasm group.Conclusion Flurbiprofen Cataplasm,with its favorable analgesic effect,is suitable for general clinical use.It can reduce stiffness,improvephysical function,and has good safety profile.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn